VC-backed Zosano Pharma rolls out IPO
Zosano Pharma Corp has launched its IPO after pricing its 4.5 million shares at $11 per share. The stock began trading Tuesday on the NASDAQ under the ticker symbol "ZSAN." Ladenburg Thalmann and Roth Capital Partners are serving as lead underwriters. Based in Fremont, California, Zosano is a biopharmaceutical company focused on transdermal drug delivery. Its backers include Nomura International, BioMed Ventures, HBM BioVentures, New Enterprise Associates and ProQuest Investments.
27 January 2015•2 mins read
